1. Home
  2. CTSO vs AACG Comparison

CTSO vs AACG Comparison

Compare CTSO & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • AACG
  • Stock Information
  • Founded
  • CTSO 1997
  • AACG 1999
  • Country
  • CTSO United States
  • AACG China
  • Employees
  • CTSO N/A
  • AACG N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • AACG Other Consumer Services
  • Sector
  • CTSO Health Care
  • AACG Real Estate
  • Exchange
  • CTSO Nasdaq
  • AACG Nasdaq
  • Market Cap
  • CTSO 61.7M
  • AACG 65.1M
  • IPO Year
  • CTSO N/A
  • AACG N/A
  • Fundamental
  • Price
  • CTSO $0.90
  • AACG $2.47
  • Analyst Decision
  • CTSO Buy
  • AACG
  • Analyst Count
  • CTSO 2
  • AACG 0
  • Target Price
  • CTSO $5.50
  • AACG N/A
  • AVG Volume (30 Days)
  • CTSO 130.7K
  • AACG 78.1K
  • Earning Date
  • CTSO 11-06-2025
  • AACG 11-06-2025
  • Dividend Yield
  • CTSO N/A
  • AACG N/A
  • EPS Growth
  • CTSO N/A
  • AACG N/A
  • EPS
  • CTSO N/A
  • AACG N/A
  • Revenue
  • CTSO $36,107,520.00
  • AACG $39,064,701.00
  • Revenue This Year
  • CTSO $11.93
  • AACG N/A
  • Revenue Next Year
  • CTSO $21.22
  • AACG N/A
  • P/E Ratio
  • CTSO N/A
  • AACG N/A
  • Revenue Growth
  • CTSO 20.18
  • AACG 15.19
  • 52 Week Low
  • CTSO $0.71
  • AACG $0.50
  • 52 Week High
  • CTSO $1.61
  • AACG $2.55
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 42.05
  • AACG 66.01
  • Support Level
  • CTSO $0.87
  • AACG $2.05
  • Resistance Level
  • CTSO $1.04
  • AACG $2.21
  • Average True Range (ATR)
  • CTSO 0.05
  • AACG 0.22
  • MACD
  • CTSO -0.00
  • AACG 0.01
  • Stochastic Oscillator
  • CTSO 21.95
  • AACG 86.48

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About AACG ATA Creativity Global

ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.

Share on Social Networks: